This study sought to test @ hypotheses : @ ) fibroblast growth factor ( FGF ) -@ identifies patients with stable ischemic heart disease ( SIHD ) at high risk of cardiovascular events independent of clinical factors , renal function , and established cardiovascular biomarkers ; and @ ) FGF-@ identifies patients who derive greater clinical benefit from angiotensin-converting enzyme inhibitor therapy .